2014 - 2017 Role of bioactive oxidized lipid in urothelial carcinoma
2007 - 2008 Improvement of renal cell carcinoma treatment using hypoxia inducible factor control
2004 - 2005 Role of Cdc25 protein in hormone refractory prostate cancer
2002 - 2003 Role of hypoxia inducible factor-1α in renal cancer
1999 - 2000 Role of metallothionein on carcinogenesis and tumor progression in bladder cancer.
1999 - 2000 Investigation of cancer growth factors in hormone refractory prostate cancer.
1998 - 1999 REDOX REGULATION BY ANTIOXIDANTS CONTAINING TRACE ELEMENTS
1997 - 1998 膀胱癌におけるシスプラチン耐性因子とアポトーシス発現についての究明
1996 - 1998 膀胱腫瘍予後規定因子としてのp53とその修飾因子の究明
1996 - 1997 Physiological and Clinical Implication of Metallothionein
1996 - 1996 腎細胞癌における予後因子としての核組織中のメタロチオネインの役割
癌細胞における低酸素と血管新生
膀胱癌の生物学的特性及び治療への応用
癌化学療法におけるSH化合物の役割
Hypoxia and neovascularization in cancer cells
Biological characterization of bladder tumor and its clinical application
Role of SH compound in cancer chemotherapy
Show all
Papers (299):
Masato Yanagi, Tomonari Kiriyama, Jun Akatsuka, Yuki Endo, Hayato Takeda, Tsutomu Hamasaki, Taiji Nishimura, Yukihiro Kondo. Preoperative analysis of factors associated with prolonged pneumoretroperitoneum time during retroperitoneal laparoscopic nephroureterectomy for upper tract urothelial carcinoma. BMC urology. 2024. 24. 1. 155-155
Masato Yanagi, Hiroyoshi Kono, Hiroyuki Muramatsu, Akifumi Katsu, Ryoji Kimata, Tsutomu Hamasaki, Yukihiro Kondo. Difficulty in Removing a Ureteral Stent post Childbirth due to Encrustation: A Case Report. The Kobe journal of medical sciences. 2024. 70. 3. E77-E80
Masato Yanagi, Norio Motoda, Akifumi Katsu, Hiroyoshi Kono, Ryoji Kimata, Tsutomu Hamasaki, Yukihiro Kondo. Preoperative oral treatment with cyclooxygenase-2 inhibitor for cystitis glandularis. IJU case reports. 2024. 7. 4. 297-300
Yoshihiko Ogata, Jun Akatsuka, Yuki Endo, Hikaru Mikami, Masato Yanagi, Hayato Takeda, Yuka Toyama, Yoichiro Yamamoto, Go Kimura, Yukihiro Kondo. Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study. BMC Urology. 2024. 24. 1
Satoko Nakayama, Emiko Yoda, Saki Yamashita, Yuka Takamatsu, Yasutomo Suzuki, Yukihiro Kondo, Shuntaro Hara. Knockdown of iPLA2γ enhances cisplatin-induced apoptosis by increasing ROS-dependent peroxidation of mitochondrial phospholipids in bladder cancer cells. Free radical biology & medicine. 2024
Clinical use of bismuth compound as an adjunct in chemotherapy with cis-DDP against human urological tumors.
Metallothionein III Birkhauser Verlag Basel 1993
Lectures and oral presentations (4):
当院における上部尿路上皮癌に対する腎盂尿管全摘術の検討
(泌尿器外科 2019)
腎平滑筋肉腫と腎平滑筋種の症例検討
(泌尿器外科 2019)
精索原発と考えられたデスモイド腫瘍の1例
(泌尿器外科 2019)
経尿道的膀胱腫瘍切除術後にカンジダ腎膿瘍を併発し腎摘出に至った一例
(泌尿器外科 2019)
Education (2):
- 1985 Nippon Medical School Medical School Department of Medicine
- 1985 Nippon Medical School Faculty of Medicine
Professional career (1):
Ph.D. of medicine (Nippon Medical School)
Work history (8):
2009/04 - 現在 Nippon Medical School Department of Urology Professor
2000/04 - 2009/03 Nippon Medical School Department of Urology Sub-Professor
1996/04 - 2000/03 Nippon Medical School. Dept. of Urology Associate Professor
1992 - 1995 Research associate in Dept. of Pharmacology, University of Pittsburgh
1990 - 1992 Research associate in Dept. of Urology, Nippon Medical School.
Kitasato University School of Pharmaceutical Sciences
Nippon Medical School
Nippon Medical School Faculty of Medicine, Department of Medicine, Department of Urology Associate professor
Show all
Committee career (2):
2014/04 - 2020/03 日本泌尿器科学会 代議員 理事
2014/04 - 2016/03 日本学術振興会 学術研究センター 研究員
Association Membership(s) (10):
米国癌学会
, 米国泌尿器科学会
, 日本癌治療学会
, 日本癌学会
, 日本泌尿器科学会
, American Cancer Association
, American Urological association
, Japanese Association of Clinical Oncology
, Japanese Association of Cancer Reserach
, Japanese Urological Association